Investigative Clinical Research, 612 Ridgely Avenue, Suite 401, — Annapolis, Maryland

Investigative Clinical Research, 612 Ridgely Avenue, Suite 401, is a clinical research site located in Annapolis, Maryland, United States 21401.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Investigative Clinical Research, 612 Ridgely Avenue, Suite 401, has participated in 1 clinical trials.

Therapeutic areas: Crohn's Disease.

Sponsors: RedHill Biopharma Limited.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigative Clinical Research, 612 Ridgely Avenue, Suite 401,?

Investigative Clinical Research, 612 Ridgely Avenue, Suite 401, has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigative Clinical Research, 612 Ridgely Avenue, Suite 401, conducted?

Investigative Clinical Research, 612 Ridgely Avenue, Suite 401, has 1 clinical trials on record. Their work covers Crohn's Disease.

Is Investigative Clinical Research, 612 Ridgely Avenue, Suite 401, accredited by Crixeo Health?

Investigative Clinical Research, 612 Ridgely Avenue, Suite 401, has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigative Clinical Research, 612 Ridgely Avenue, Suite 401,?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.